A.M. Vitals: Pharma Companies Tapping Early-Stage Biotech Products 0
Posted on
August 05, 2010 by
admin
A.M. Vitals: Pharma Companies Tapping Early-Stage Biotech Products
Also: NJ suit on involuntary medication; FDA wants to clarify device-approval process; Consumer Reports identifies supplement ingredients with scary side effects.
Read more on Wall Street Journal Blogs
